Valproate Toxicity: Risk-Screening Strategies

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Journal of Child Neurology

• Publication date

  1991-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/088307389100600101PMID 2002198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproate‐Induced Hepatic Injury: Analyses of 23 Fatal Cases

  2007cited by this paper
• Sodium Valproate in the Induction of Unusual Hepatotoxicity

  2007cited by this paper
• Valproate-induced coma with ketosis and carnitine insufficiency.

  1990cited by this paper
• Markedly increased omega-oxidation of valproate in fulminant hepatic failure.

  1990cited by this paper
• Disorders of Branched-Chain Amino Acid Metabolism

  1990cited by this paper
• Markedly Increased ω‐Oxidation of Valproate in Fulminant Hepatic Failure

  1990cited by this paper
• Valproic acid hepatic fatalities.

  1989cited by this paper
• Hepatic hydrolysis of octanoyl-CoA and valproyl-CoA in control and valproate-fed animals.

  1988cited by this paper
• Fatal Liver Failure in 16 Children with Valproate Therapy

  1988cited by this paper
• Adult Onset Systemic Carnitine Deficiency: Favorable Response to L-Carnitine Supplementation

  1987cited by this paper
• Valproic acid hepatic fatalities

  1987cited by this paper
• A Suspected Case of Late-Onset Sodium-Valproate-lnduced Hepatic Failure

  1987cited by this paper
• A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance.

  1985cited by this paper
• Diagnostic and Therapeutic Implications of Medium-Chain Acylcarnitines in the Medium-Chain Acyl-CoA Dehydrogenase Deficiency

  1985cited by this paper
• Valproic acid associated abnormalities of carnitine metabolism.

  1985cited by this paper
• Hepatotoxicity to sodium valproate: a review.

  1984cited by this paper
• Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.

  1984cited by this paper
• Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-Carnitine

  1984cited by this paper
• L-Carnitine insufficiency in disorders of organic acid metabolism: response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria.

  1984cited by this paper
• Progressive poliodystrophy (alpers') disease) with a defect in cytochrome in muscle: a report of two unrelated patients

  1983cited by this paper
• Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups.

  1983cited by this paper
• Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes.

  1983cited by this paper
• [Role of hyperammonemia in stuporous states induced by sodium valproate].

  1983cited by this paper
• Influence of valproic acid on hepatic carbohydrate and lipid metabolism.

  1983cited by this paper
• The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats.

  1983cited by this paper
• Acute valproate intoxication: biochemical investigations and hemodialysis treatment.

  1983cited by this paper
• C6—C10-Dicarboxylic Aciduria: Investigations of a Patient with Riboflavin Responsive Multiple Acyl-CoA Dehydrogenation Defects

  1982cited by this paper
• L-carnitine therapy in propionicacidaemia.

  1982cited by this paper
• Hyperammonemia with valproic acid therapy.

  1981cited by this paper
• Pyruvate dehydrogenase deficiency restricted to brain

  1981cited by this paper
• Valproate, hyperammonemia, and hyperglycinemia.

  1980cited by this paper
• Reye-like syndrome associated with valproic acid therapy.

  1979cited by this paper
• Stupor Following Administration of Valproic Acid to Patients Receiving Other Antiepileptic Drugs

  1979cited by this paper
• Metabolism in rats in vivo of RS-2-methylbutyrate and n-butyrate labeled with stable isotopes at various positions. Mechanism of biosynthesis and degradation of ethylmalonyl semialdehyde and ethylmalonic acid.

  1979cited by this paper
• A direct hepatotoxic effect of valproic acid.

  1979cited by this paper
• Acute hepatic failure associated with the use of sodium valproate.

  1979cited by this paper
• Valporic acid and coma.

  1979cited by this paper
• Acute intoxication with sodium valproate

  1979cited by this paper
• Recurrent hypoglycemia associated with glutaric aciduria type II in an adult.

  1979cited by this paper
• Treatment of accidental sodium valproate overdose with an opiate antagonist

  1979cited by this paper
• Effect of valproic acid on hepatic function

  1978cited by this paper
• New defect in fatty-acid metabolism with hypoglycemia and organic aciduria.

  1977cited by this paper
• Glutaric aciduria type II: report on a previously undescribed metabolic disorder.

  1976cited by this paper
• The syndrome of systemic carnitine deficiency

  1975cited by this paper
• Diffuse Cerebral Degeneration in Infancy (Alpers' Disease)

  1963cited by this paper

• Antiepileptic Drug Therapy in Children

  2012cites this paper
• The structure-activity relationship of the 3-oxy site in the anticonvulsant (R)-N-benzyl 2-acetamido-3-methoxypropionamide.

  2010cites this paper
• Vigabatrin Caused Rapidly Progressive Deterioration in Two Cases With Early Myoclonic Encephalopathy Associated With Nonketotic Hyperglycinemia

  2006cites this paper
• Screening Electroencephalograms in Autism Spectrum Disorders: Evidence-Based Guideline

  2005cites this paper
• Factores que condicionan a las reacciones adversas del ácido valproico en un Hospital Pediátrico en el Estado de Hidalgo, México

  2005cites this paper
• [Antiepileptic drugs used in childhood. New products and new concepts].

  2003cites this paper
• Fármacos antiepilépticos utilizados en la infancia. Nuevos productos y nuevos conceptos

  2003cites this paper
• Reye’s Syndrome and Related Chemical Toxicity

  2002cites this paper
• Intoxikationen und Enzephalopathien unter Valproinsäuretherapie

  2002cites this paper
• Klinische Pharmakologie von Valproinsäure: Resorption, Metabolisierung und Elimination

  2002cites this paper
• Hyperammoniémie, hypoglycémie et thrombopénie chez un nouveau-né de mère traitée par valproate

  2001cites this paper
• [Hyperammonia, hypoglycemia and thrombocytopenia in a newborn after materanl treatment with valproate].

  2001cites this paper
• Apoptosis in Diseases of the Liver

  2001cites this paper
• Use of Topiramate in Childhood Generalized Seizure Disorders

  2000cites this paper
• Idiosyncratic Reactions: New Methods of Identifying High‐risk Patients

  2000cites this paper
• The Role of Carnitine Supplementation during Valproic Acid Therapy

  2000cites this paper
• Inappropriate liver transplantation in a child with Alpers–Huttenlocher syndrome misdiagnosed as valproate‐induced acute liver failure

  2000cites this paper
• Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid‐induced liver damage

  2000cites this paper
• Treatment of epilepsies in adults

  1999cites this paper
• Treatment of seizures and epilepsy in children and adolescents

  1998cites this paper
• Importance of Basic Residues in the Nucleocapsid Sequence for Retrovirus Gag Assembly and Complementation Rescue

  1998cites this paper
• Effect of L‐Carnitine Supplementation on Acute Valproate Intoxication

  1996cites this paper
• Divalproex Sodium in Headache: Literature Review and Clinical Guidelines

  1996cites this paper
• Divalproex Sodium: Migraine Treatment and Monitoring

  1996cites this paper
• Carnitine Deficiency in Epilepsy: Risk Factors and Treatment

  1995cites this paper
• Antiepileptic drug therapy in the United States: a review of clinical studies and unmet needs.

  1995cites this paper
• Standard Approach to Antiepileptic Drug Treatment in the United States

  1994cites this paper
• Valproate-induced hepatic failure in a case of cytochromec oxidase deficiency

  1994cites this paper
• γ‐Vinyl GABA (Vigabatrin) and Mood Disturbances

  1994cites this paper
• Hepatotoxic effects in a child receiving valproate and carnitine.

  1993cites this paper
• Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity

  1992cites this paper
• Klinische Pharmakologie von Valproinsäure: Resorption und Metabolisierung

  1992cites this paper
• Stellenwert von Valproinsäure in der Behandlung von Epilepsien des Kindesalters

  1992cites this paper
• ARTICLES RECEIVED IN 1991

  1992cites this paper